Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Stifel Nicolaus

Stifel Nicolaus started coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research report sent to investors on Monday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $28.00 target price on the stock.

Kestra Medical Technologies Stock Performance

NASDAQ:KMTS opened at $24.92 on Monday. Kestra Medical Technologies has a 52-week low of $20.00 and a 52-week high of $25.98.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.